BioMarin Pharmaceutical I... (BMRN)
NASDAQ: BMRN
· Real-Time Price · USD
58.02
-0.28 (-0.48%)
At close: Aug 14, 2025, 3:59 PM
58.20
0.31%
Pre-market: Aug 15, 2025, 08:52 AM EDT
BioMarin Pharmaceutical Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.21B | 1.05B | 942.84M | 675.45M | 972.15M | 747M | 755.13M | 785.41M | 694.38M | 580.07M | 724.53M | 761.51M | 619.8M | 605.44M | 587.28M | 617.14M | 641.53M | 667.31M |
Short-Term Investments | 218.31M | 223.53M | 194.86M | 255M | 252.2M | 299.58M | 318.68M | 340.43M | 476.58M | 572.02M | 567.01M | 512.25M | 489.94M | 450.8M | 426.6M | 462.33M | 481.86M | 420.18M |
Long-Term Investments | 508.59M | 506.72M | 521.24M | 561.99M | 567.74M | 620.55M | 611.13M | 548M | 385.78M | 340.63M | 333.83M | 372.3M | 412.5M | 462.83M | 507.79M | 466.62M | 350.24M | 321.13M |
Other Long-Term Assets | 249.19M | 235.65M | 251.39M | 199.31M | 180.12M | 184.79M | 171.54M | 165.07M | 144.17M | 150.06M | 176.24M | 151.79M | 151.8M | 149.19M | 151.76M | 144.71M | 141.66M | 141.2M |
Receivables | 855.86M | 739.18M | 660.53M | 777.55M | 691.23M | 637.16M | 633.7M | 572.5M | 610.22M | 597.91M | 461.32M | 419.62M | 466.51M | 430.15M | 373.4M | 374.94M | 424.42M | 396.1M |
Inventory | 1.34B | 1.27B | 1.23B | 1.18B | 1.18B | 1.14B | 1.11B | 1.03B | 975.55M | 918.92M | 894.08M | 839.46M | 802.32M | 786.36M | 776.67M | 749.41M | 710.98M | 713.93M |
Other Current Assets | 177.18M | 181.54M | 201.53M | 169.26M | 160.43M | 163.29M | 141.39M | 224.81M | 193.39M | 173.18M | 104.52M | 149.85M | 139.03M | 121.28M | 110.44M | 107.75M | 99.05M | 91.25M |
Total Current Assets | 3.81B | 3.47B | 3.23B | 3.06B | 3.26B | 2.99B | 2.96B | 2.96B | 2.95B | 2.84B | 2.75B | 2.68B | 2.52B | 2.39B | 2.27B | 2.31B | 2.36B | 2.29B |
Property-Plant & Equipment | 1.03B | 1.03B | 1.04B | 1.05B | 1.05B | 1.06B | 1.07B | 1.07B | 1.07B | 1.07B | 1.07B | 1.05B | 1.05B | 1.04B | 1.04B | 1.02B | 1.03B | 1.02B |
Goodwill & Intangibles | 435.82M | 443.55M | 451.48M | 457.12M | 461.73M | 475.85M | 490.9M | 498.68M | 506.54M | 522.19M | 534.77M | 550.22M | 565.57M | 570.45M | 584.85M | 584.69M | 590.5M | 602.1M |
Total Long-Term Assets | 3.65B | 3.68B | 3.76B | 3.79B | 3.81B | 3.89B | 3.89B | 3.8B | 3.61B | 3.59B | 3.62B | 3.58B | 3.63B | 3.67B | 3.73B | 3.67B | 3.54B | 3.52B |
Total Assets | 7.46B | 7.15B | 6.99B | 6.85B | 7.07B | 6.87B | 6.84B | 6.76B | 6.56B | 6.43B | 6.38B | 6.26B | 6.15B | 6.06B | 6B | 5.98B | 5.9B | 5.81B |
Account Payables | n/a | 293.75M | 235.4M | 312.32M | 257.41M | 292.24M | 315.51M | 301.37M | 277.94M | 264.78M | 231.24M | 207.16M | 199.25M | 187.81M | 193M | 203.32M | 176.07M | 165M |
Deferred Revenue | n/a | n/a | 1.37M | 2.35M | 1.91M | -593.54M | -1.74B | -301.37M | -286.24M | n/a | 711K | 415K | 305K | 306K | 6.96M | 253.73M | -11.02M | -11.23M |
Short-Term Debt | n/a | n/a | n/a | 7.49M | 494.84M | 494.36M | 493.88M | 493.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 684.25M | 628.21M | 223.14M | 171.74M | 14.79M | 133.03M | 150.52M | 185.77M | 142.99M | 150.33M | 122.77M | 202.49M | 168.11M | 204.65M | 123.74M | 211.64M | 172.91M | 157.39M |
Total Current Liabilities | 684.25M | 628.21M | 606.99M | 715.66M | 1.07B | 1.09B | 117.7M | 1.16B | 597.23M | 598.23M | 588.88M | 521.02M | 464.73M | 490.42M | 539.82M | 514.9M | 443.34M | 430.04M |
Long-Term Debt | 596.16M | 595.65M | 595.14M | 594.63M | 594.12M | 593.61M | 593.1M | 592.59M | 1.08B | 1.08B | 1.08B | 1.08B | 1.08B | 1.08B | 1.08B | 1.08B | 1.08B | 1.08B |
Other Long-Term Liabilities | 148.82M | 129.69M | 128.82M | 127.51M | 119.37M | 117.35M | 119.94M | 105.46M | 98.12M | 92.42M | 100.02M | 92.47M | 95.26M | 100.91M | 79.84M | 118.33M | 136.47M | 136.88M |
Total Long-Term Liabilities | 744.98M | 725.34M | 723.96M | 722.14M | 713.49M | 710.96M | 713.03M | 698.04M | 1.18B | 1.18B | 1.18B | 1.17B | 1.18B | 1.18B | 1.19B | 1.2B | 1.21B | 1.21B |
Total Liabilities | 1.43B | 1.35B | 1.33B | 1.44B | 1.78B | 1.8B | 1.89B | 1.86B | 1.78B | 1.77B | 1.77B | 1.7B | 1.64B | 1.67B | 1.73B | 1.71B | 1.66B | 1.64B |
Total Debt | 596.16M | 595.65M | 602.71M | 602.69M | 1.1B | 1.09B | 1.09B | 1.09B | 1.08B | 1.08B | 1.08B | 1.08B | 1.08B | 1.09B | 1.08B | 1.08B | 1.08B | 1.08B |
Common Stock | -11.48M | n/a | 191K | 191K | 190K | 190K | 189K | 188K | 188K | 188K | 186K | 186K | 186K | 185K | 184K | 184K | 183K | 183K |
Retained Earnings | 231.52M | -9.01M | -194.69M | -319.64M | -425.72M | -532.89M | -621.55M | -641.93M | -682.31M | -738.35M | -789.2M | -788.95M | -777.23M | -804.89M | -925.69M | -867.79M | -831.3M | -844.24M |
Comprehensive Income | -44.56M | 19.15M | 61.65M | 4.65M | 15.13M | -12.75M | -28.79M | 6.26M | -18.62M | -10.72M | -3.87M | 30.75M | 18.47M | -877K | 14.43M | 10.24M | -939K | 5M |
Shareholders Equity | 6.03B | 5.79B | 5.66B | 5.41B | 5.29B | 5.07B | 4.95B | 4.9B | 4.78B | 4.66B | 4.6B | 4.57B | 4.5B | 4.39B | 4.27B | 4.27B | 4.24B | 4.16B |
Total Investments | 726.9M | 730.26M | 716.1M | 816.98M | 819.94M | 299.58M | 929.82M | 888.43M | 862.35M | 912.65M | 900.84M | 884.55M | 902.45M | 913.63M | 934.39M | 928.95M | 832.1M | 741.3M |